Home

Johnson & Johnson Innovation - JJDC, Inc.

CIK 924020 · last filed 2026-01-08

Johnson & Johnson Innovation - JJDC, Inc. is a corporate insider who has filed 20 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing shows the insider sold $448.1K of CVRX on Jan 8, 2026. Across all open-market trades the lifetime net is −$90.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.5M across reported positions. The firm reports its address in New Brunswick, NJ. 58 SEC filings were submitted jointly with & JOHNSON JOHNSON.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$24.54M

Companies

7

Total Filings

20

Lifetime Open-Market Net

-$90.70M

Filer Profile

Reported Address
410 GEORGE STREET, SUITE 308
NEW BRUNSWICK, NJ 08901
Phone
(732) 524-3218
State of Incorporation
DE
Formerly Known As
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (2004–2015)
Related Filers
& JOHNSON JOHNSON — 58 joint filings, latest 2026-01-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CVRX 10%+ Owner 4,024,861 $2.83 $11.39M -$660.4K 6 2026-01-08
MGTX 10%+ Owner 0 $13.26 $0 $0 1 2023-09-18
INSP 10%+ Owner 197,863 $66.48 $13.15M $0 1 2018-05-07
NERV 10%+ Owner 0 $4.12 $0 $0 1 2017-09-14
NEVRO CORP (NVRO) Delisted 10%+ Owner 2,066,740 $5.84 $12.07M -$95.42M 2 2015-06-08
Neurogene Inc. (AQXP) Delisted 10%+ Owner 1,664,821 — — $5.38M 7 2015-02-03
GENOCEA BIOSCIENCES, INC. (GNCA) Delisted 10%+ Owner 173,581 $0.00 $104 $0 1 2014-02-11

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-08 CVRX Sell (S) −44,674 -$448.1K EDGAR
2025-11-14 CVRX Sell (S) −2,000 -$20.0K EDGAR
2024-03-06 CVRX Mixed +1,215,710 $5.3K EDGAR
2024-02-02 CVRX Other (J) — $0 EDGAR
2023-09-18 MGTX Other (J) −6,641,064 $0 EDGAR
2023-09-18 CVRX Other (J) −3,495,575 $0 EDGAR
2021-07-02 CVRX Conv (C) +6,991,150 $0 EDGAR
2018-07-20 — Conv (C) +4,800,000 $0
2018-05-07 INSP Conv (C) +470,502 $0 EDGAR
2017-09-14 NERV Other (J) −7,784,512 -$778 EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.